ChemNavigator's Database Exceeds Two Million Compounds and 33 Worldwide Suppliers
World's Largest Collection of Accessible Drug-Like Compounds Doubled in Size in One Year
Advertisement
ChemNavigator, the cheminformatics company whose chemical-data management products expedite drug discovery, today announced its iResearch™ System Library now exceeds two million drug-like compounds, constituting a significant resource for life science researchers and further widening the company's competitive lead.
The iResearch System Library is the world's largest database of commercially accessible, drug-like screening compounds. Life science organizations worldwide use the library as a "probe" to quickly and efficiently identify promising new directions for drug discovery research. ChemNavigator further reduces the time-consuming drug discovery process by procuring the compounds in its library through its international supplier network.
"The huge number of compounds in the iResearch System Library, combined with our automated chemical-data management tools and the integration of scientific knowledge on compounds, eases the task of drug discovery," stated Scott Hutton, president and CEO. "The size of the library has doubled in the last year and this growth includes compounds from established industry leaders such as SPECS and BioSPECS, as well as novel compounds from small research labs around the world. The diversity of the library is second to none."
Earlier this month, ChemNavigator announced that through a partnership with Structural Bioinformatics, Inc., the three-dimensional version of the library can be screened in silico against SBI's more than 2600 3-D protein targets to identify active compounds.
ChemNavigator's library is available through several business models, including custom library design projects, and one-time or yearly subscriptions.
Other news from the department research and development
Most read news
More news from our other portals
Last viewed contents
Selective conversion of reactive lithium compounds made possible - Until now, unwanted by-products have always been produced during the reactions - The catalyst opens up new applications
Category:Pharmaceutical_companies_of_Japan
Purac joins BE-Basic consortium for bio-based economy
Cabot Corporation starts first world class fumed silica new facility in China
Altuglas International : price increase for acrylic sheets and blocks
Syngenta opens crop protection plant in China
Clariant developing next-gen ammonia cracking catalysts to support the global hydrogen revolution - Hydrogen to be converted to ammonia to facilitate transportation then reconverted at the point of use
Superatoms mimic elements: Research gives new perspective on periodic table
Cabot Corporation Acquires Assets Of Superior MicroPowders, LLC
Noveon Expands Personal Care Business with Acquisition of Scher Chemicals, Inc.
From backyard pool chemical to nanomaterial - Could a molecule used for disinfection provide the key to creating a new form of DNA nanomaterials?
